Home › Funds › MFS Investment Management › VRTX
MFS Investment Management position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)423.05K sh
Reported value held$214.65M
Portfolio Weight0.07%
First reportedQ2 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2021 | 3.15M | $635.90M | New |
| Q3 2021 | 3.15M | $571.24M | Hold |
| Q4 2021 | 3.19M | $701.55M | Add |
| Q2 2022 | 4.34M | $1.22B | Add |
| Q3 2022 | 4.35M | $1.26B | Hold |
| Q4 2022 | 4.11M | $1.19B | Reduce |
| Q1 2023 | 4.05M | $1.27B | Reduce |
| Q2 2023 | 3.94M | $1.39B | Reduce |
| Q3 2023 | 3.89M | $1.35B | Reduce |
| Q4 2023 | 3.63M | $1.48B | Reduce |
| Q1 2024 | 2.80M | $1.17B | Reduce |
| Q2 2024 | 2.75M | $1.29B | Reduce |
| Q3 2024 | 2.91M | $1.35B | Add |
| Q4 2024 | 2.29M | $921.58M | Reduce |
| Q1 2025 | 2.02M | $981.72M | Reduce |
| Q2 2025 | 1.28M | $571.79M | Reduce |
| Q3 2025 | 503.16K | $197.06M | Reduce |
| Q4 2025 | 211.93K | $96.08M | Reduce |
| Q1 2026 | 327.50K | $149.40M | Add |
| Q2 2026 | 423.05K | $214.65M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026